"Die Thoraxklinik Heidelberg ist ein Krankenhaus der Maximalversorgung mit einer über 100 jährigen Geschichte und seit 2009 zertifiziertes Lungenkrebszentrum sowie akkreditiertes Weaningzentrum."

During the past decade, Thoraxclinic at the University Hospital Heidelberg conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Thoraxclinic at the University Hospital Heidelberg" are "Pulmonary Hypertension" (2 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials) and "Connective Tissue Disease" (1 trials). Many other conditions were trialed in "Thoraxclinic at the University Hospital Heidelberg" in a lesser frequency.

Most popular intervention types in "Thoraxclinic at the University Hospital Heidelberg" are "Behavioral" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "exercise and respiratory therapy" (1 trials), "exercise training" (1 trials) and "sedentary control group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Thoraxclinic at the University Hospital Heidelberg" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Thoraxclinic at the University Hospital Heidelberg". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Thoraxclinic at the University Hospital Heidelberg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Thoraxclinic at the University Hospital Heidelberg, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".